Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasms, Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05923567
What this trial is testing

New Predictive Marker for Pancreatic Cancer Using CA19-9 and Fecal Elastase

Who this might be right for
Paancreatic Cancer
Gangnam Severance Hospital 150
Testing effectiveness (Phase 2)Study completedNCT01210911
What this trial is testing

Metformin Combined With Chemotherapy for Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 120
Testing effectiveness (Phase 2)Looking for participantsNCT06411795
What this trial is testing

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Who this might be right for
Duodenal NeoplasmPancreatic Neoplasm
Masonic Cancer Center, University of Minnesota 78
Early research (Phase 1)Study completedNCT01189929
What this trial is testing

Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
OncoMed Pharmaceuticals, Inc. 57
Not applicableStudy completedNCT05226572
What this trial is testing

Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results

Who this might be right for
Pancreatic AdenocarcinomaPancreas CancerPancreas Metastases
University of Bologna 462
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Not applicableUnknownNCT03770559
What this trial is testing

The Therapeutic Evaluation(Both Short-term and Long-term Outcome) of Minimal Invasive Radical Antegrade Modular Pancreatosplenectomy for Left-sided Pancreatic Cancer Patients

Who this might be right for
Pancreatic CancerSurgery
Peking Union Medical College Hospital 125
Testing effectiveness (Phase 2)Study completedNCT04431258
What this trial is testing

ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study

Who this might be right for
Pancreatic Cancer
Ability Pharmaceuticals SL 150
Not applicableUnknownNCT06319755
What this trial is testing

Characteristics of Intestinal Microbiome Following Pancreatic Surgery

Who this might be right for
Pancreatic CancerMicrobiotaPancreatoduodenectomy
Royal Prince Alfred Hospital, Sydney, Australia 20
Testing effectiveness (Phase 2)Study completedNCT01360593
What this trial is testing

Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
David A. Clump, MD, PhD 35
Post-approval studies (Phase 4)UnknownNCT03269955
What this trial is testing

The Effect of Application of TachoSil® in Pancreatoduodenectomy

Who this might be right for
Pancreatic NeoplasmPancreatic Periampullary CancerPancreatic Bordeline Tumor
Asan Medical Center 126
Not applicableUnknownNCT05593393
What this trial is testing

A Long-term Follow-up Cohort Study in Patients With Intraductal Papillary Mucinous Neoplasm

Who this might be right for
IPMN, Pancreatic
Peking Union Medical College Hospital 1,500
Testing effectiveness (Phase 2)Study completedNCT00201838
What this trial is testing

Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsAdenocarcinoma
Ohio State University Comprehensive Cancer Center 38
Early research (Phase 1)Study completedNCT03307148
What this trial is testing

Stromal TARgeting for PAncreatic Cancer (STAR_PAC)

Who this might be right for
Pancreatic Adenocarcinoma
Barts & The London NHS Trust 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT04482309
What this trial is testing

T-DXd in Patients With Selected HER2 Expressing Tumors

Who this might be right for
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal CancerPart 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
AstraZeneca 477
Not applicableNot Yet RecruitingNCT06167421
What this trial is testing

Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal Pancreatectomy

Who this might be right for
Pancreatic Tumor, BenignPancreatic Neuroendocrine TumorSolid Pseudopapillary Tumor of the Pancreas
Fudan University 240
Not applicableUnknownNCT03809247
What this trial is testing

Microbial Diversity of Pancreatic Diseases

Who this might be right for
Pancreatic CancerPancreatic Disease
Ruijin Hospital 330
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07773363
What this trial is testing

Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Tang-Du Hospital 37
Testing effectiveness (Phase 2)Study completedNCT01978184
What this trial is testing

Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine

Who this might be right for
Pancreatic Cancer
Nathan Bahary, MD 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT03785249
What this trial is testing

Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 731
Next Page